CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancer

Journal of Surgical Oncology

Volumn 106, Issue 6, 2012, Pages 765-771

  Yu, Qi Ming ^a   Wang, Xin Bao ^a   Luo, Jun ^a   Wang, Shi ^a   Fang, Xian Hua ^a   Yu, Jiang Liu ^a   Ling, Zhi Qiang ^a  

^a ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

CDH1; gastric cancer; methylation; preoperative peritoneal washes (PPW); prognosis; tumor progression

Indexed keywords

UVOMORULIN;

ADULT; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CHRONIC GASTRITIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERITONEUM LAVAGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN METHYLATION; STOMACH CANCER; STOMACH MUCOSA;

ADULT; AGED; CADHERINS; CPG ISLANDS; DNA METHYLATION; FEMALE; GASTRIC MUCOSA; HUMANS; MALE; MIDDLE AGED; PERITONEUM; PROGNOSIS; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS;

EID: 84867864891     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23116     Document Type: Article

References (43)

1. Wang XQ, Yan H, Terry PD, et al.: Interactions between CagA and smoking in gastric cancer. World J Gastroenterol 2011; 17: 3330-3334.
2. Alfaro EE, Lauwers GY:, Early gastric neoplasia: Diagnosis and implications. Adv Anat Pathol 2011; 18: 268-280.
3. Qiao XT, Gumucio DL:, Current molecular markers for gastric progenitor cells and gastric cancer stem cells. J Gastroenterol 2011; 46: 855-865.
4. Ibáñez de Cáceres I, Cairns P:, Methylated DNA sequences for early cancer detection, molecular classification and chemotherapy response prediction. Clin Transl Oncol 2007; 9: 429-437.
5. Fiegl H, Elmasry K:, Cancer diagnosis, risk assessment and prediction of therapeutic response by means of DNA methylation markers. Dis Markers 2007; 23: 89-96.
6. Ahmed IA, Pusch CM, Hamed T, et al.: Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA. Cancer Genet Cytogenet 2010; 199: 96-100.
7. Leung WK, To KF, Man EP, et al.: Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer. Am J Gastroenterol 2005; 100: 2274-2279.
8. Rouprêt M, Hupertan V, Yates DR, et al.: A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis. BJU Int 2008; 101: 1448-1453.
9. Feng Q, Hawes SE, Stern JE, et al.: Promoter hypermethylation of tumor suppressor genes in urine from patients with cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2007; 16: 1178-1184.
10. Ibanez de Caceres I, Battagli C, Esteller M, et al.: Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients. Cancer Res 2004; 64: 6476-6481.
11. Hwang SH, Kim KU, Kim JE, et al.: Detection of HOXA9 gene methylation in tumor tissues and induced sputum samples from primary lung cancer patients. Clin Chem Lab Med 2011; 49: 699-704.
12. Li M, Zhang P:, The function of APC/CCDH1 in cell cycle and beyond. Cell Div 2009; 4: 2.
13. Masterson J, O'Dea S:, Posttranslational truncation of E-cadherin and significance for tumour progression. Cells Tissues Organs 2007; 185: 175-179.
14. Czyzewska J, Guzinska-Ustymowicz K, Ustymowicz M, et al.: The expression of E-cadherin-catenin complex in patients with advanced gastric cancer: Role in formation of metastasis. Folia Histochem Cytobiol 2010; 48: 37-45.
15. Kim J, Hong SJ, Park JY, et al.: Epithelial-mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma. Cancer Sci 2010; 101: 1521-1528.
16. Celebiler Cavusoglu A, Kilic Y, et al.: Predicting invasive phenotype with CDH1, CDH13, CD44, and TIMP3 gene expression in primary breast cancer. Cancer Sci 2009; 100: 2341-2345.
17. Jeong DH, Youm MY, Kim YN, et al.: Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: Correlation with clinicopathologic characteristics. Int J Gynecol Cancer 2006; 16: 1234-1240.
18. Florl AR, Steinhoff C, Muller M, et al.: Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation. Br J Cancer 2004; 91: 985-994.
19. Harbst K, Staaf J, Masback A, et al.: Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns. Melanoma Res 2010; 20: 381-391.
20. Kim DS, Kim MJ, Lee JY, et al.: Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features. Cancer 2007; 110: 2785-2792.
21. Matsumura T, Makino R, Mitamura K:, Frequent downregulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Clin Cancer Res 2001; 7: 594-599.
22. Ling ZQ, Li P, Ge MH, et al.: Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer. Int J Mol Med 2011; 27: 625-635.
23. Barber M, Murrell A, Ito Y, et al.: Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J Pathol 2008; 216: 295-306.
24. Berx G, van Roy F:, Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol 2009; 1: a003129.
25. Ling ZQ, Tanaka A, Li P, et al.: Microsatellite instability with promoter methylation and silencing of hMLH1 can regionally occur during progression of gastric carcinoma. Cancer Lett 2010; 297: 244-251.
26. Dikshit RP, Mathur G, Mhatre S, et al.: Epidemiological review of gastric cancer in India. Indian J Med Paediatr Oncol 2011; 32: 3-11.
27. Piazuelo MB, Epplein M, Correa P:, Gastric cancer: An infectious disease. Infect Dis Clin North Am 2010; 24: 853-869.
28. Wu WK, Cho CH, Lee CW, et al.: Dysregulation of cellular signaling in gastric cancer. Cancer Lett 2010; 295: 144-153.
29. Oguma K, Oshima H, Oshima M:, Inflammation, tumor necrosis factor and Wnt promotion in gastric cancer development. Future Oncol 2010; 6: 515-526.
30. Saikawa Y, Fukuda K, Takahashi T, et al.: Gastric carcinogenesis and the cancer stem cell hypothesis. Gastric Cancer 2010; 13: 11-24.
31. Herceg Z, Vaissière T:, Epigenetic mechanisms and cancer: An interface between the environment and the genome. Epigenetics 2011; 6: 804-819.
32. Tycko B:, Cancer epigenetics and targeted therapies. Oncology (Williston Park) 2011; 25: 231.
33. Brait M, Sidransky D:, Cancer epigenetics: Above and beyond. Toxicol Mech Methods 2011; 21: 275-288.
34. Nawijn MC, Hackett TL, Postma DS, et al.: E-cadherin: Gatekeeper of airway mucosa and allergic sensitization. Trends Immunol 2011; 32: 248-255.
35. Xue WC, Chan KY, Feng HC, et al.: Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma. J Mol Diagn 2004; 6: 326-334.
36. Saha B, Kaur P, Tsao-Wei D, et al.: Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone. Prostate 2008; 68: 1681-1688.
37. Caldeira JR, Prando EC, Quevedo FC, et al.: CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC Cancer 2006; 6: 48.
38. Matsusaka S, ChÃn K, Ogura M, et al.: Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer. Cancer Sci 2010; 101: 1067-1071.
39. Lurje G, Schiesser M, Claudius A, et al.: Circulating tumor cells in gastrointestinal malignancies: Current techniques and clinical implications. J Oncol 2010; 392652.
40. Takeuchi H, Kitagawa Y:, Circulating tumor cells in gastrointestinal cancer. J Hepatobiliary Pancreat Sci 2010; 17: 577-582.
41. Hiraki M, Kitajima Y, Koga Y, et al.: Aberrant gene methylation is a biomarker for the detection of cancer cells in peritoneal wash samples from advanced gastric cancer patients. Ann Surg Oncol 2011; 18: 3013-3019.
42. Hiraki M, Kitajima Y, Sato S, et al.: Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer. World J Gastroenterol 2010; 16: 330-338.
43. Kague E, Thomazini CM, Pardini MI, et al.: Methylation status of CDH1 gene in samples of gastric mucous from Brazilian patients with chronic gastritis infected by Helicobacter pylori. Arq Gastroenterol 2010; 47: 7-12.